UM NOVO METABOLITO DE COLESTEROL, 5-COLESTEN, 3, 25-DIOL, DISSULFATO (25HCDS) PARA TERAPIA DE DISTÚRBIOS METABÓLICOS, HIPERLIPIDEMIA, DIABETES, DOENÇAS DO FÍGADO GORDUROSO E ATEROSCLEROSE

• 收藏
• 分享

专利权人:

VIRGINIA COMMONWEALTH UNIVERSITY

发明人:

SHUNLIN REN

申请号：

PT13775974

公开号：

PT2836502T

申请日:

2013.03.15

申请国别(地区):

PT

年份:

2017

代理人:

摘要：

5-cholesten-3, 25-diol, disulfate (25HCDS) has been found to be an authentic PPAR ³ agonist and LXR antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/